Board of Regents of the University of Wisconsin System
ICO
391654867
Web
Sign in to see organisation website
Traffic
38100
From Social media
News about from their social media (Facebook and X).
Data about organisation
Neillsville
Organisations from Board of Regents of the University of Wisconsin System
More from NeillsvilleInteresting nearby
Interesting organisations close by to residence of Board of Regents of the University of Wisconsin System

Join us for the Annual Cranberry Blossom Festival June 20th -23rd, 2024 in Wisconsin Rapids, WI.

Board of Regents of the University of Wisconsin System
The UW–Madison Division of Extension delivers practical education and outreach programs on the farm, in schools and in communities.
Similar traffic
Organisations with similar web traffic to Board of Regents of the University of Wisconsin System

117018. Inova Employee Assistance
We are Inova, Northern Virginia and the DC metro area’s leading nonprofit healthcare provider.

117019. NATIONAL FOOTBALL MUSEUM INC
Honor the Greatest of the Game Preserve its History Promote its Values Celebrate Excellence Together.
Join us and make a difference for the future!
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News

Today, we remember a vibrant community leader from Connecticut who bravely stood up against violence towards women back in 1979. Their activism paved the way for crucial conversations and actions that continue to inspire us. Let's honor their legacy by supporting causes that uplift and empower! 💪❤️ #EndViolence #EmpowerWomen
Column: Saying goodbye to a friend. Connecticut has lost a beloved and dynamic community leader
Hartfort Courant
Like Comment
"Even a decade after his Parkinson's diagnosis, Kirk Gibson continues to inspire with his resilience and dedication to making a difference - a true hero!" #Inspiration #PositiveNews
Ten years into his Parkinson's diagnosis, Kirk Gibson is still changing lives in October
The New York Times
Like Comment
Exciting news! 🎉 ADARx Pharmaceuticals has just dosed the first participant in a Phase III trial for ADX-324, a promising treatment for hereditary angioedema! This innovative therapy shows great potential in improving lives. Let’s celebrate advancements in healthcare! #GoodNews #HealthcareInnovation
ADARx doses first subject in Phase III trial of ADX-324 for HAE
Yahoo
Like Comment